Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies. (Q51201268)

1 April 2018

title

Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies. (English)

1 reference

1 April 2018

cost-effectiveness analysis

1 reference

1 reference

Ravi N Sharaf

1

1 reference

1 April 2018

Uri Ladabaum

series ordinal

2

1 reference

1 April 2018

language of work or name

English

0 references

publication date

18 December 2012

1 reference

1 April 2018

The American Journal of Gastroenterology

published in

1 reference

1 April 2018

volume

108

1 reference

1 April 2018

issue

1

1 reference

1 April 2018

page(s)

120-132

1 reference

1 April 2018

Colorectal cancer screening: a comparison of 35 initiatives in 17 countries.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Randomised controlled trial of faecal-occult-blood screening for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Randomised study of screening for colorectal cancer with faecal-occult-blood test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Association of colonoscopy and death from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Once-Only Sigmoidoscopy in Colorectal Cancer Screening: Follow-up Findings of the Italian Randomized Controlled Trial--SCORE

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Determining the cause of dyspnoea: linguistic and biological descriptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Trends in colonoscopy for colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Colorectal cancer test use from the 2005 National Health Interview Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Measuring the quality of colorectal cancer screening: the importance of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Cost implications of new treatments for advanced colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Projections of the costs associated with colorectal cancer care in the United States, 2000-2020.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Protection by endoscopy against death from colorectal cancer. A case-control study among veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Colorectal cancer screening differential costs for younger versus older Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Polyps and cancer of the large bowel: a necropsy study in Liverpool

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Adenomatous lesions of the large bowel:An autopsy survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Advances in chemotherapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Systemic therapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Colorectal cancer screening: clinical guidelines and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Polyp miss rate determined by tandem colonoscopy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Complications of screening flexible sigmoidoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Endoscopic perforation of the colon: lessons from a 10-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Risk of perforation from a colonoscopy in adults: a large population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Quality of life in survivors of colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Colonoscopic screening of average-risk women for colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

Randomized Trial of Different Screening Strategies for Colorectal Cancer: Patient Response and Detection Rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.380

21 January 2018

Identifiers

DOI

10.1038/AJG.2012.380

1 reference

1 April 2018

1 reference

1 April 2018